JP2017520547A5 - - Google Patents

Download PDF

Info

Publication number
JP2017520547A5
JP2017520547A5 JP2016572800A JP2016572800A JP2017520547A5 JP 2017520547 A5 JP2017520547 A5 JP 2017520547A5 JP 2016572800 A JP2016572800 A JP 2016572800A JP 2016572800 A JP2016572800 A JP 2016572800A JP 2017520547 A5 JP2017520547 A5 JP 2017520547A5
Authority
JP
Japan
Prior art keywords
formula
compound
hydrogen
alkyl
defined above
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016572800A
Other languages
English (en)
Japanese (ja)
Other versions
JP6785666B2 (ja
JP2017520547A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/063942 external-priority patent/WO2015197534A2/en
Publication of JP2017520547A publication Critical patent/JP2017520547A/ja
Publication of JP2017520547A5 publication Critical patent/JP2017520547A5/ja
Application granted granted Critical
Publication of JP6785666B2 publication Critical patent/JP6785666B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016572800A 2014-06-23 2015-06-22 1,3−ベンゾジオキソール複素環化合物の調製方法 Active JP6785666B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14173397.2 2014-06-23
EP14173397 2014-06-23
PCT/EP2015/063942 WO2015197534A2 (en) 2014-06-23 2015-06-22 Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Publications (3)

Publication Number Publication Date
JP2017520547A JP2017520547A (ja) 2017-07-27
JP2017520547A5 true JP2017520547A5 (show.php) 2018-07-26
JP6785666B2 JP6785666B2 (ja) 2020-11-18

Family

ID=50980952

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016572800A Active JP6785666B2 (ja) 2014-06-23 2015-06-22 1,3−ベンゾジオキソール複素環化合物の調製方法

Country Status (18)

Country Link
US (1) US9908894B2 (show.php)
EP (1) EP3157930B1 (show.php)
JP (1) JP6785666B2 (show.php)
KR (1) KR20170016894A (show.php)
CN (1) CN106459081B (show.php)
AU (1) AU2015279428B2 (show.php)
BR (1) BR112016029510A2 (show.php)
CA (1) CA2953284A1 (show.php)
DK (1) DK3157930T3 (show.php)
ES (1) ES2702451T3 (show.php)
IL (1) IL249336A0 (show.php)
MX (1) MX2016016378A (show.php)
PL (1) PL3157930T3 (show.php)
PT (1) PT3157930T (show.php)
RU (1) RU2697251C2 (show.php)
TW (1) TW201613934A (show.php)
WO (1) WO2015197534A2 (show.php)
ZA (1) ZA201608442B (show.php)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3390407T (pt) 2015-12-18 2023-11-03 Union Therapeutics As Métodos para a preparação de compostos heterocíclicos de 1,3-benzodioxole
CN110741005B (zh) 2017-06-20 2024-04-12 联合疗法公司 用于制备1,3-苯并二氧杂环戊烯杂环化合物的方法
CN111727191B (zh) 2017-12-15 2024-01-05 联合疗法公司 取代的氮杂环丁烷二氢噻吩并吡啶类化合物及其作为磷酸二酯酶抑制剂的用途
USD914676S1 (en) 2018-05-11 2021-03-30 Samsung Electronics Co., Ltd. Notebook computer
ES2957495T3 (es) 2019-01-15 2024-01-19 Union Therapeutics As Formulaciones de comprimidos de liberación modificada que contienen inhibidores de fosfodiesterasa
BR112023019309A2 (pt) 2021-03-22 2023-10-31 Union Therapeutics As Tratamento de hidradenite supurativa com orismilaste
GB202205715D0 (en) 2022-04-19 2022-06-01 Union Therapeutics As Treatment of neutrophilic dermatoses
GB202306662D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Dosage regimen
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE325110T1 (de) * 1995-05-19 2006-06-15 Kyowa Hakko Kogyo Kk Sauerstoff enthaltende heterocyclische verbindungen
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
DE10205274A1 (de) * 2002-02-08 2003-08-21 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen
JPWO2004005276A1 (ja) * 2002-07-03 2005-11-04 協和醗酵工業株式会社 1,3−ベンゾジオキソール−2−スピロシクロアルカン誘導体の製造法
ATE496029T1 (de) * 2006-07-14 2011-02-15 Chiesi Farma Spa Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren
JP5342451B2 (ja) * 2006-12-22 2013-11-13 レオ ファーマ アクティーゼルスカブ Pde4阻害剤として有用な置換アセトフェノン
UA98639C2 (en) * 2007-02-28 2012-06-11 Лео Фарма А/С Phosphodiesterase inhibitors
MY150075A (en) * 2007-02-28 2013-11-29 Leo Pharma As Novel phosphodiesterase inhibitors
CN102958937B (zh) * 2010-06-24 2016-03-30 利奥制药有限公司 作为磷酸二酯酶抑制剂的苯并二氧杂环戊烯或苯并二氧杂环庚烯杂环化合物
WO2014096018A1 (en) * 2012-12-19 2014-06-26 Leo Pharma A/S Methods for the preparation of substituted acetophenones
PT3390407T (pt) * 2015-12-18 2023-11-03 Union Therapeutics As Métodos para a preparação de compostos heterocíclicos de 1,3-benzodioxole

Similar Documents

Publication Publication Date Title
JP2017520547A5 (show.php)
RU2017101808A (ru) Способы получения 1, 3-бензодиоксольных гетероциклических соединений
JP2018193405A5 (show.php)
JP2015524406A5 (show.php)
JP2018529687A5 (show.php)
JP2017522357A5 (show.php)
JP2017501197A5 (show.php)
JP2015536898A5 (show.php)
JP2017505801A5 (show.php)
JP2010513494A5 (show.php)
US10167246B2 (en) Preparative method for carboxylic acids
CN104803956A (zh) 非罗考昔的一种合成方法
JP2018507858A5 (show.php)
JP2012251113A5 (show.php)
JP2018528948A5 (show.php)
JP2021046426A5 (show.php)
JP2017533926A5 (show.php)
JP2013064130A5 (show.php)
JP2019521165A5 (show.php)
JP2017517513A5 (show.php)
JP2016515555A5 (show.php)
CN105037319B (zh) 金催化的分子内重氮偶联选择性生成反式大环烯烃的方法
CN109952294A (zh) 4-((6-(2-(2,4-二氟苯基)-1,1-二氟-2-羟基-3-(5-巯基-1h-1,2,4-三唑-1-基)丙基)吡啶-3-基)氧基)苄腈及制备方法
CN102351621A (zh) 一种n-砜基脒的制备方法
CN103073492A (zh) 2-[3-(s)-[3-[2-(7-氯-2-喹啉基)乙烯基]苯基]-3-羟基丙基]苯甲酸酯的合成方法